BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/7/2023ACC: 0001562180-23-001079
Officer· Chief Commercial Officer
Since Sep 2021
+4.63K
Net shares
Net buyer
$93.6K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
6.75K acquired · 2.12K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.75K
Price / share
—
Trade value
—
% of position
1073.1%
2/3/2023
629.00→7.38K
Common Stock
Direct
Shares
−2.12K
Price / share
$44.16
Trade value
$93.58K
% of position
28.7%
2/3/2023
7.38K→5.26K
Total
Net shares
+4.63K
Net value
-$93.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2023 | A · Award | +6.75K | — | — | 1073.1% | 629.00 | 7.38K |
| Common Stock Direct | 2/3/2023 | F · Tax Withholding | −2.12K | $44.16 | $93.58K | 28.7% | 7.38K | 5.26K |
| Total | +4.63K | -$93.58K | ||||||
Derivative Transactions0
No derivative transactions reported